Evidence map›Paper›PMID 29632327›Full record

ArticleScientific reports2018

Surface display of PbrR on Escherichia coli and evaluation of the bioavailability of lead associated with engineered cells in mice.

Changye Hui, Yan Guo, Wen Zhang, Chaoxian Gao, Xueqin Yang, Yuting Chen, Limei Li, Xianqing Huang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Frontiers in nutrition · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Improved Monitoring of Low-Level Transcription inFrontiers in microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Changye HuiDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China. hcy_sypu@hotmail.com.ORCID 0000-0002-0958-1986
Yan GuoDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Wen ZhangDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Chaoxian GaoDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Xueqin YangDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Yuting ChenDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Limei LiDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Xianqing HuangDepartment of Pathology & Toxicology, Shenzhen Prevention and Treatment Center for Occupational Disease, Shenzhen, 518020, P.R. China.
Shenzhen Center for Disease Control and Prevention · CNShenzhen Occupational Disease Prevention Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human exposure to lead mainly occurs by ingestion of contaminated food, water and soil. Blocking lead uptake in the gastrointestinal tract is a novel prevention strategy. Whole-cell biosorbent for lead was constructed with PbrR genetically engineered on the cell surface of Escherichia coli (E. coli), a predominant strain among intestinal microflora, using lipoprotein (Lpp)-OmpA as the anchoring protein. In vitro, the PbrR displayed cells had an enhanced ability for immobilizing toxic lead(II) ions from the external media at both acidic and neutral pH, and exhibited a higher specific adsorption for lead compared to other physiological two valence metal ions. In vivo, the persistence of recombinant E. coli in the murine intestinal tract and the integrity of surface displayed PbrR were confirmed. In addition, oral administration of surface-engineered E. coli was safe in mice, in which the concentrations of physiological metal ions in blood were not affected. More importantly, lead associated with PbrR-displayed E. coli was demonstrated to be less bioavailable in the experimental mouse model with exposure to oral lead. This is reflected by significantly lower blood and femur lead concentrations in PbrR-displayed E. coli groups compared to the control. These results open up the possibility for the removal of toxic metal ions in vivo using engineered microorganisms as adsorbents.

Indexed as

AnimalsBacterial Outer Membrane ProteinsBacterial ProteinsBiological AvailabilityBiotransformationCell MembraneEscherichia coliFemurGenetic EngineeringHydrogen-Ion ConcentrationIntestinesLeadMaleMicePilot ProjectsSerumBacterial Outer Membrane ProteinsBacterial ProteinsLeadOMPA outer membrane proteins

Identifiers

PMID29632327
PMCPMC5890273
OpenAlexW2796591826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.